SEX DIFFERENCE IN THE ASSOCIATION BETWEEN INSULIN RESISTANCE AND ESTIMATED GLOMERULAR FILTRATION RATE IN ADULTS WITHOUT CHRONIC KIDNEY DISEASE

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/835af5ee6f65903e6ba981ce67f97412.pdf
SEX DIFFERENCE IN THE ASSOCIATION BETWEEN INSULIN RESISTANCE AND ESTIMATED GLOMERULAR FILTRATION RATE IN ADULTS WITHOUT CHRONIC KIDNEY DISEASE

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Darinorn
Pleanrungsi
Panchanit Yongkiatkan panchanit.yk@docchula.com University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States -
Natanon Chamnarnphol natanon.c@gmail.com University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States -
Sorawis Ngaohirunpat sorawis.ngao@gmail.com University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States -
Issaree Boonyawannukul doctorpoundpoundz.fbi@gmail.com University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States - Faculty of Medicine Srinagarind Hospital, Khon Kaen University Department of Internal Medicine Khon Kaen Thailand
Napat Wongmat napat.6402@gmail.com University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States -
Nongnapas Assawamasbunlue nongnapas.assawa@gmail.com University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States -
Thanin Asawaroekwisoot thaninasawaroekwisoot@gmail.com University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States -
Thanasin Chalermchat thanasin.cha@student.mahidol.edu University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States - Mahidol University Faculty of Medicine Siriraj Hospital Bangkok Thailand
Nopavit Mohpichai nopavit.moh@gmail.com University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States - Mahidol University Faculty of Medicine Ramathibodi Hospital Bangkok Thailand
Katanyu Siwawut katanyu.siw@student.mahidol.edu University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States - Mahidol University Faculty of Medicine Siriraj Hospital Bangkok Thailand
Darinorn Pleanrungsi darinorn.ple@student.mahidol.edu University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States * Mahidol University Faculty of Medicine Siriraj Hospital Bangkok Thailand
Chutawat Kookanok chutawat.koo@pcm.ac.th University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States - Interfaith Medical Center Department of Medicine Brooklyn, New York United States
Kyunghee Lee hicaru1004@hanmail.net University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States - Daegu Veterans Health Service Medical Center Division of Nephrology, Department of Internal Medicine Daegu Korea (Republic of)
Surasak Kantachuvesiri surasak.kan@mahidol.ac.th Faculty of Medicine Ramathibodi Hospital, Mahidol University Excellent Center for Organ Transplantation Bangkok Thailand -
Ekamol Tantisattamo ekamoltan@gmail.com University of California Irvine School of Medicine American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine Orange, California United States - Mahidol University Excellent Center for Organ Transplantation, Faculty of Medicine Ramathibodi Hospital Bangkok Thailand Tibor Rubin Veterans Affairs Medical Center, Veterans Affairs Long Beach Healthcare System Nephrology Section, Department of Medicine Long Beach, California United States

Insulin resistance is an established risk factor for chronic kidney disease (CKD). The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), a surrogate marker of insulin resistance, is widely used in population-based studies. However, the sex-specific relationship between insulin resistance, as assessed by HOMA-IR, and kidney function among individuals without CKD remains unclear. This study aimed to evaluate the association between HOMA-IR and estimated glomerular filtration rate (eGFR), sexing male and female participants without CKD.

We conducted a retrospective cross-sectional analysis using data from the 2021–2023 National Health and Nutrition Examination Survey (NHANES). HOMA-IR was calculated as (fasting insulin [µU/mL] × fasting glucose [mg/dL]) ÷ 405 and categorized into tertiles. Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI 2021 equation, and participants with eGFR ≤ 60 mL/min/1.73 m² were excluded. Associations between eGFR and HOMA-IR tertiles were examined using multivariable linear regression, adjusting for demographic variables, comorbidities, laboratory parameters, and socioeconomic factors.

Among 2,593 adults included, the mean age was 54.10 ± 16.86 years, 55.38% were female, and 10.80% had diabetes. The median [IQR] HOMA-IR was 0.25 [0.23–0.27], and the median [IQR] eGFR was 96.86 [89.03–109.91] mL/min/1.73 m². In fully adjusted linear regression models, higher HOMA-IR was associated with lower eGFR (β = −5.06, 95% CI −8.15 to −1.98). When categorized into tertiles, participants in the highest HOMA-IR tertile had a greater decline in eGFR compared with those in the lowest tertile (T2: β = −0.61, 95% CI −1.03 to −0.19; p = 0.004; T3: β = −0.94, 95% CI −1.44 to −0.45; p < 0.001). In sex-stratified analyses, the association remained significant among males (T2: β = −0.98, 95% CI −1.03 to −0.34; p = 0.003; T3: β = −1.08, 95% CI −1.78 to −0.37; p = 0.003), whereas among females, it was significant only in the highest tertile (T2: β = −0.27, 95% CI −0.82 to 0.29; p = 0.35; T3: β = −0.99, 95% CI −1.68 to −0.29; p = 0.01).

Using ordinal logistic regression, participants in the highest HOMA-IR tertile also had higher odds of being in a more advanced CKD stage (G2 vs G1) compared with those in the lowest tertile (T2: OR = 1.24, 95% CI 0.73–2.11; p = 0.41; T3: OR = 1.84, 95% CI 1.05–3.21; p = 0.03).

 

Higher HOMA-IR was independently associated with lower eGFR, particularly among in non-CKD male participants, even after adjusted for diabetes. These findings highlight the need for longitudinal studies to explore the sex-specific mechanisms, such as hormonal alteration, linking insulin resistance to CKD progression.

Kewords